Catalyst Wire Dossier Catalyst Wire Dossier

AKTEN

LIDOCAINE HYDROCHLORIDE ANHYDROUS · Thea Pharma Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AKTEN, covering 2008-10-07 to 2025-11-21. Get the full timeline:

Most recent: FDA Approved: AKTEN — Supplemental Application (Thea Pharma Inc.)

See pricing